Kenneth C. Frazier - 03 May 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: Executive Chair, Director
Signature: /s/ Kelly E. W. Grez as Attorney-in-Fact for Kenneth C. Frazier
Issuer symbol: MRK
Transactions as of: 03 May 2022
Net transactions value: $0
Form type: 4
Filing time: 05 May 2022, 16:53:42 UTC
Previous filing: 28 Feb 2022
Next filing: 26 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						706,283	03 May 2022	Direct	F1
holding	MRK	Common Stock - 401(k) Plan						4,414	03 May 2022	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Award	$0	+28,703		$0.000000	28,703	03 May 2022	Common Stock	28,703		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Holdings include shares acquired in dividend reinvestment transactions.
F2	Includes shares acquired and dividends earned through April 7, 2022 in the Merck U.S. Savings Plan, a 401(k) plan.
F3	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4	These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 5/3/2023.